| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) | 
|---|
| 05/29/2013 | EP2595643A1 Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment | 
| 05/29/2013 | EP2595642A2 Compositions comprising derivatives of essential oil compounds and use in personal care products | 
| 05/29/2013 | EP2595627A1 Use of uleine for the prevention and/or the treatment of infectious diseases | 
| 05/29/2013 | EP2595615A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease | 
| 05/29/2013 | EP2595613A1 Method of preventing or treating viral infection | 
| 05/29/2013 | EP2595473A2 Transgenic plants expressing a viral antifungal protein | 
| 05/29/2013 | CN1968707B Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases | 
| 05/29/2013 | CN1525866B Treatment using neublastin polypeptides | 
| 05/29/2013 | CN103124737A Immunogenic composition or vaccine against Gram-negative bacterial, for example neiserial, infrection or disease | 
| 05/29/2013 | CN103124560A Method for preparing an extract of centella asiatica | 
| 05/29/2013 | CN103123359A Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease | 
| 05/29/2013 | CN103122360A Chimeric adenoviral vectors | 
| 05/29/2013 | CN103122354A Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant | 
| 05/29/2013 | CN103122353A Porcine O-type foot-and-mouth disease virus recombinant baculovirus as well as preparation method and application thereof | 
| 05/29/2013 | CN103122352A Porcine circovirus II-type recombinant baculovirus as well as preparation method and application thereof | 
| 05/29/2013 | CN103122347A Lyase for killing staphylococcus and application of lyase | 
| 05/29/2013 | CN103122336A Goose parvovirus H-strain and application thereof in preventing and treating gosling plague | 
| 05/29/2013 | CN103122025A Small molecule-polypeptide conjugate for inhibiting human immunodeficiency virus (HIV) infection | 
| 05/29/2013 | CN103122024A Artificially designed HIV (human immunodeficiency virus)-infection-resisting polypeptide, composition and application | 
| 05/29/2013 | CN103122014A Clindamycin isomer, analytical preparation method and application thereof | 
| 05/29/2013 | CN103122013A Hydrogen-removing clindamycin as well as analysis preparation method and application thereof | 
| 05/29/2013 | CN103122001A Polo-like kinase inhibitors | 
| 05/29/2013 | CN103120793A Traditional Chinese medicine composition for preventing and treating recurrent respiratory tract infection of children and application thereof | 
| 05/29/2013 | CN103120791A Traditional Chinese medicine composition for treating vital myocarditis and preparation method thereof | 
| 05/29/2013 | CN103120780A Traditional Chinese medicine with disinfection function | 
| 05/29/2013 | CN103120776A Radix bupleuri and baical skullcap root detoxification granules | 
| 05/29/2013 | CN103120774A Preparation method of tablet for warming, heat-clearing and removing toxin | 
| 05/29/2013 | CN103120773A Medicinal composition for treating mycoplasma pneumonia in children | 
| 05/29/2013 | CN103120768A Medicament for treating vital myocarditis and cardiomyopathy | 
| 05/29/2013 | CN103120748A Traditional Chinese medicine for treating hepatitis | 
| 05/29/2013 | CN103120747A Drug for treating vital myocarditis | 
| 05/29/2013 | CN103120746A Medicament for treating viral hepatitis | 
| 05/29/2013 | CN103120745A Traditional Chinese medicine lung-clearing decoction for treating mycoplasma pneumonia in children | 
| 05/29/2013 | CN103120733A Medicine for treating myocarditis | 
| 05/29/2013 | CN103120721A Chinese medicinal composition for treating wind-heat common cold and preparation method and application thereof | 
| 05/29/2013 | CN103120719A Pure traditional Chinese medicine composition for treating sacbrood virus of bees and preparation method thereof | 
| 05/29/2013 | CN103120716A Chinese herbal preparation for preventing ascites syndrome of grass carp | 
| 05/29/2013 | CN103120714A Chinese medicinal preparation for treating suppurative otitis media | 
| 05/29/2013 | CN103120713A Extraction technology for extracting total phenolic acid from lonicera japonica flowers | 
| 05/29/2013 | CN103120711A Medicine composition for treating hepatitis, and preparation method and novel application thereof | 
| 05/29/2013 | CN103120708A Application of white atractylodes rhizome in preparation of anti-albumoses virus drug | 
| 05/29/2013 | CN103120707A Mouth disinfectant prepared by using traditional Chines medicine boat-fruited sterculia seeds | 
| 05/29/2013 | CN103120699A Application of iridoid in preparation of anti-SARS (severe acute respiratory syndromes) medicines | 
| 05/29/2013 | CN103120698A Application of triterpenoid saponins compound in preparation of anti-pathogenic microorganism medicines | 
| 05/29/2013 | CN103120692A Preparation method for injection cefoperazone sodium tazobactam sodium composition | 
| 05/29/2013 | CN103120689A Application of pyrazol compound as mycobacterium tuberculosis inhibitor | 
| 05/29/2013 | CN103120687A Application of Eryngiolide A in medicine for resisting tubercle bacillus | 
| 05/29/2013 | CN103120668A Application of Eryngiolide A in anti-helicobacter pylori drug | 
| 05/29/2013 | CN103120662A Application of Eryngiolide A in medicine for treating dengue virus infection | 
| 05/29/2013 | CN103120661A Application of Eryngiolide A in medicine for resisting influenza A virus | 
| 05/29/2013 | CN103120648A Oral isoprinosine preparation and preparation method thereof | 
| 05/29/2013 | CN103120642A Gel used for skin diseases and preparation method thereof | 
| 05/29/2013 | CN103120632A Hand sanitizer with aloe extract | 
| 05/29/2013 | CN102755325B Cefoxitin sodium medicinal composition, powder injection and preparation method thereof | 
| 05/29/2013 | CN102719397B Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus) | 
| 05/29/2013 | CN102670656B Chinese medicinal enteric capsules for treating medium-term and advanced tumors and chronic hepatitis B and preparation method for capsules | 
| 05/29/2013 | CN102626392B Solid preparation of doxycycline ambroxol medicine compound | 
| 05/29/2013 | CN102626389B Ornidazole liposome injection | 
| 05/29/2013 | CN102614182B Solid preparation of compound ammonia phenol renin medicine composition liposome | 
| 05/29/2013 | CN102526473B Medicament for treating chronic virus B hepatitis | 
| 05/29/2013 | CN102526082B Compound glycyrrhizin soluble powder for livestock and preparation method thereof | 
| 05/29/2013 | CN102512511B Ginseng taste liver-protecting tablet for treating liver injury and preparation method thereof | 
| 05/29/2013 | CN102423293B Microemulsion gel preparation of oxiconazole nitrate | 
| 05/29/2013 | CN102327278B Application of carborane derivatives, nano compound preparation and application of nano compound preparation | 
| 05/29/2013 | CN102260325B Antibacterial peptide NX-16, and preparation method and application thereof | 
| 05/29/2013 | CN102219750B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase | 
| 05/29/2013 | CN102204968B External defervescence liquid medicine for treating infant anemopyretic cold | 
| 05/29/2013 | CN102204887B In-situ formed acyclovir spraying agent and preparation method thereof | 
| 05/29/2013 | CN102178659B Clarithromycin entericcoated tablet and preparation method thereof | 
| 05/29/2013 | CN102133193B Faropenem sodium powder injection | 
| 05/29/2013 | CN102008459B Antibacterial agents | 
| 05/29/2013 | CN101926995B Asparagus immunologic adjuvant and influenza vaccines containing same | 
| 05/29/2013 | CN101889953B Device and method for manufacturing drug smoke liquid and drug smoke | 
| 05/29/2013 | CN101868472B Antibacterial aminoglycoside analogs | 
| 05/29/2013 | CN101835765B Alkylsulfonyl-substituted thiazolide compounds | 
| 05/29/2013 | CN101646674B Indolobenzazepine derivatives for the treatment of hepatitis c | 
| 05/29/2013 | CN101628911B Antibiotic drug | 
| 05/29/2013 | CN101597230B Beta,beta-dimethyl-acry-lalkannin and application in preparing medicines for inhibiting drug-resistant bacteria | 
| 05/29/2013 | CN101565359B Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation | 
| 05/29/2013 | CN101490023B Modulators of pharmacokinetic properties of therapeutics | 
| 05/29/2013 | CN101434593B Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof | 
| 05/29/2013 | CN101429185B Two-crystal type of substance of meletin, production method, medicament composition and uses thereof | 
| 05/29/2013 | CN101417937B Beta-aldehyde ketones antibacterial compounds and use thereof | 
| 05/29/2013 | CN101384575B Tiglien-3-one derivatives | 
| 05/28/2013 | US8450367 Sulfur derivatives as chemokine receptor modulators | 
| 05/28/2013 | US8450345 Iminosugars and methods of treating viral diseases | 
| 05/28/2013 | US8449865 Drying process | 
| 05/28/2013 | CA2790294C .alpha.-crystalline form of carbabenzpyride | 
| 05/28/2013 | CA2744756C Monocarbams and their use as antibacterial agent | 
| 05/28/2013 | CA2731995C Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor | 
| 05/28/2013 | CA2727715C Vaccine composition | 
| 05/28/2013 | CA2720946C Compounds and compositions as protein kinase inhibitors | 
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof | 
| 05/28/2013 | CA2685447C Pharmaceutical composition | 
| 05/28/2013 | CA2582760C Modulators of hcv replication | 
| 05/28/2013 | CA2577918C Vaccine composition against hepatitis c virus | 
| 05/28/2013 | CA2577467C Hiv inhibiting 5-heterocyclyl pyrimidines | 
| 05/28/2013 | CA2561066C Antiviral 4-aminocarbonylamino-substituted imidazole compounds | 
| 05/28/2013 | CA2550222C Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases | 
| 05/28/2013 | CA2537137C Use of modified cyclosporins for the treatment of hcv disorders |